[Study on Realgar inducing apoptosis in T lymphocytic cell line CEM].

@article{Zhang2003StudyOR,
  title={[Study on Realgar inducing apoptosis in T lymphocytic cell line CEM].},
  author={Chen Zhang and Shi-lin Huang and Yang Xiang and Ai-xia Guo},
  journal={Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine},
  year={2003},
  volume={1 1},
  pages={
          42-3
        }
}
  • Chen Zhang, Shi-lin Huang, +1 author A. Guo
  • Published 1 May 2003
  • Biology, Medicine
  • Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
OBJECTIVE To study the Realgar induced T lymphocytic leukemia cell line CEM apoptosis in vitro. METHODS CEM cells were incubated with Realgar. Cell proliferation inhibition was determined by MTT. Cell cycle, apoptosis, Apo2.7 and Fas were measured by cytometer. RESULTS Realgar inhibited the proliferation of CEM cell line. The cells treated with Realgar showed a Sub-G(0)/G(1) apoptotic peak in DNA distribution histogram, increment of Apo2.7 protein expression, and arrested cells in G(2)/M… 
Arsenic disulfide induces apoptosis of human diffuse large B cell lymphoma cells involving Bax cleavage.
TLDR
As2S2 inhibited proliferation and induced apoptosis of LY1 and LY8 cells in a concentration- and time-dependent manner and was partly due to the induction of mitochondrial-dependent apoptosis involving Bax cleavage.
Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells
TLDR
Investigating the indirubin-enhanced effects of arsenic disulfide (As2S2) on the proliferation and apoptosis of diffuse large B-cell lymphoma (DLBCL) cells demonstrated that with regard to antitumor activities, As2 S2 served as the principal drug, whereas indirUBin served asThe adjuvant drug.
Arsenic in Cancer Treatment: Challenges for Application of Realgar Nanoparticles (A Minireview)
TLDR
This review primary focuses on the application of arsenic sulfide (realgar) for treatment of various forms of cancer in vitro and in vivo.
Arsenic bioleaching in medical realgar ore and arsenicbearing refractory gold ore by combination of Acidithiobacillus ferrooxidans and Acidithiobacillus thiooxidans
Purpose: To develop a novel biotechnological method for removing toxic arsenic from two kinds of representative arsenic-containing ores using different mixed mesophilic acidophiles. Methods:
indirubin‐enhanced effects of arsenic disulfide (As2S2) on the proliferation and apoptosis of diffuse large B-cell lymphoma
  • 2015
...
1
2
...